Inventor
HABASH LOUIS
US21 patents
⚠️ This page may combine multiple inventors who share the name “HABASH LOUIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HABASH LOUIS
17 patentsUS11324737B1May 10, 2022
Modulating expression level of a gene encoding a heat shock protein by treating a human subject with a nitroxide
HABASH LOUIS6 citations85
US10874654B2Dec 29, 2020
Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS5 citations83
US10231959B2Mar 19, 2019
Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS5 citations83
US9700550B1Jul 11, 2017
Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS7 citations83
US9579311B1Feb 28, 2017
Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS10 citations83
US9545398B1Jan 17, 2017
Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS9 citations83
US8563581B2Oct 22, 2013
Nitroxides for use in treating predisposed or at risk patients
HABASH LOUIS9 citations82
US11510913B1Nov 29, 2022
Modulating expression level of a gene encoding an apurinic/apyrimidinic endodeoxyribonuclease protein by treating a human subject with a nitroxide
HABASH LOUIS3 citations72
US10828291B2Nov 10, 2020
Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxide
HABASH LOUIS2 citations72
US10441578B2Oct 15, 2019
Altering expression level of glutathione S-transferase genes by treating a human subject with a nitroxide
HABASH LOUIS6 citations72
US10159665B2Dec 25, 2018
Preventing amyloid plaque formation by treating a human subject with a nitroxide
HABASH LOUIS2 citations72
US10064852B2Sep 4, 2018
Decreasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS5 citations72
US9744162B1Aug 29, 2017
Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS2 citations72
US11998536B2Jun 4, 2024
Decreasing expression level of proteasome subunit genes by treating a human subject with a nitroxide
HABASH LOUIS0 citations62
US11839606B2Dec 12, 2023
Increasing expression level of apoptosis-related genes by treating a human subject with a nitroxide
HABASH LOUIS0 citations62
US12208089B2Jan 28, 2025
Adjusting expression level of a gene encoding a Sirtuin protein by treating a human subject with a nitroxide
HABASH LOUIS0 citations51
US11819500B2Nov 21, 2023
T-cell regulation in t-cell mediated diseases by reducing pathogenic function of TH17 in a human subject through treatment with a nitroxide
HABASH LOUIS0 citations51
MITOS PHARMACEUTICALS INC
4 patentsUS9101619B2Aug 11, 2015
Nitroxides for use in treating or preventing diabetes and obesity
MITOS PHARMACEUTICALS INC10 citations81
US10245256B2Apr 2, 2019
Nitroxides for use in treating or preventing diabetes and obesity
MITOS PHARMACEUTICALS INC2 citations70
US9522143B2Dec 20, 2016
Nitroxides for use in treating or preventing diabetes and obesity
MITOS PHARMACEUTICALS INC3 citations70
US9522144B2Dec 20, 2016
Nitroxides for use in treating or preventing diabetes and obesity
MITOS PHARMACEUTICALS INC2 citations60